Mers-cov specific polypeptide and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- STATION OF VIRUS PREVENTION & CONTROL CHINA DISEASES PREVENTION & CONTROL CENT
- Publication Date
- 2019-08-06
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a MERS-CoV specific polypeptide and an application thereof, and belongs to the field of immune detection. Background technique
[0002] In June 2012, the first case of MERS was found in Saudi Arabia. Subsequently, more cases were reported in the Arabian Peninsula and spread to Asia, Africa, Europe and North America. The mortality rate was as high as 35.7%. In July 2015, There is also an imported case of infection in our country. The development of safe and effective vaccines is one of the important means to control the spread of MERS-CoV. T cells play a very important role in virus clearance. In the evaluation of the immune effect of MERS-CoV vaccine, the evaluation of T cell immune response is particularly important. The establishment of a susceptible mouse model of MERS-CoV provides a good animal model for the development of its vaccine. It is particularly important to develop efficient, rapid, and sensitive detection meth...